NCCN Advances Regional Cancer Care Customization at World Cancer Congress
Event summary
- NCCN presented two research abstracts at the 2026 World Cancer Congress in Hong Kong, focusing on regional cancer care customization.
- 61% of active National Cancer Control Plans (NCCPs) reference existing guidelines, but most lack implementation measurement systems.
- NCCN collaborated with Chinese experts to adapt head and neck cancer guidelines for nasopharyngeal carcinoma treatment in China.
- Nearly half of NCCN Guidelines users are international, with significant adoption in China, India, and South Korea.
The big picture
NCCN's work at the World Cancer Congress highlights the growing need for regionally tailored cancer care solutions. As healthcare systems struggle with equity and resource allocation, the organization's guideline adaptation model could become a critical tool for improving outcomes in high-burden regions. With nearly half of its users outside the U.S., NCCN is positioning itself as a key player in global oncology standardization efforts.
What we're watching
- Implementation Tracking
- Whether NCCN can drive adoption of measurement systems to ensure equitable guideline implementation across regions.
- Regional Adaptation Pace
- The pace at which NCCN can scale its guideline adaptation model to other high-burden cancer types and geographies.
- Policy Influence
- How NCCN's research will impact the development and revision of National Cancer Control Plans globally.
Related topics